Wang L, Alfson K, Eaton B, Mattix M, Goez-Gazi Y, Holbrook M
Molecules. 2025; 30(4).
PMID: 40005201
PMC: 11858388.
DOI: 10.3390/molecules30040892.
Goens M, Howard E, Warner B, Susta L, Wootton S
Viruses. 2024; 16(11).
PMID: 39599908
PMC: 11599079.
DOI: 10.3390/v16111794.
Richards P, Briseno J, Brunton B, Maury W
Methods Mol Biol. 2024; 2877():183-198.
PMID: 39585622
PMC: 11727417.
DOI: 10.1007/978-1-0716-4256-6_13.
Takahashi T, Amarbayasgalan S, Ueno S, Sugiura Y, Dorjsuren E, Shimizu K
J Virol. 2024; 98(12):e0177224.
PMID: 39498987
PMC: 11651003.
DOI: 10.1128/jvi.01772-24.
Wang S, Li W, Wang Z, Yang W, Li E, Xia X
Signal Transduct Target Ther. 2024; 9(1):223.
PMID: 39256346
PMC: 11412324.
DOI: 10.1038/s41392-024-01917-x.
An update on nonhuman primate usage for drug and vaccine evaluation against filoviruses.
de La Vega M, Xiii A, Massey S, Spengler J, Kobinger G, Woolsey C
Expert Opin Drug Discov. 2024; 19(10):1185-1211.
PMID: 39090822
PMC: 11466704.
DOI: 10.1080/17460441.2024.2386100.
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system.
Ilinykh P, Huang K, Gunn B, Kuzmina N, Kedarinath K, Jurado-Cobena E
Commun Biol. 2024; 7(1):871.
PMID: 39020082
PMC: 11255267.
DOI: 10.1038/s42003-024-06556-0.
Mapping of susceptibility loci for Ebola virus pathogenesis in mice.
Schafer A, Marzi A, Furuyama W, Catanzaro N, Nguyen C, Haddock E
Cell Rep. 2024; 43(5):114127.
PMID: 38652660
PMC: 11348656.
DOI: 10.1016/j.celrep.2024.114127.
Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies.
Wirchnianski A, Nyakatura E, Herbert A, Kuehne A, Abbasi S, Florez C
PLoS Pathog. 2024; 20(4):e1012134.
PMID: 38603762
PMC: 11037526.
DOI: 10.1371/journal.ppat.1012134.
Key considerations to improve the normalization, interpretation and reproducibility of morbidity data in mammalian models of viral disease.
Belser J, Kieran T, Mitchell Z, Sun X, Mayfield K, Tumpey T
Dis Model Mech. 2024; 17(3).
PMID: 38440823
PMC: 10941659.
DOI: 10.1242/dmm.050511.
Natural history of Ebola virus disease in rhesus monkeys shows viral variant emergence dynamics and tissue-specific host responses.
Normandin E, Triana S, Raju S, Lan T, Lagerborg K, Rudy M
Cell Genom. 2024; 3(12):100440.
PMID: 38169842
PMC: 10759212.
DOI: 10.1016/j.xgen.2023.100440.
Filoviruses: Scientific Gaps and Prototype Pathogen Recommendation.
Dupuy L, Spiropoulou C, Towner J, Spengler J, Sullivan N, Montgomery J
J Infect Dis. 2023; 228(Suppl 6):S446-S459.
PMID: 37849404
PMC: 11009505.
DOI: 10.1093/infdis/jiad362.
Mouse Models of Henipavirus Infection.
Iampietro M, Barron S, Duthey A, Horvat B
Methods Mol Biol. 2023; 2682:137-147.
PMID: 37610579
DOI: 10.1007/978-1-0716-3283-3_10.
The Susceptibility of BALB/c Mice to a Mouse-Adapted Ebola Virus Intravaginal Infection.
Escaffre O, Juelich T, Smith J, Zhang L, Bourne N, Freiberg A
Viruses. 2023; 15(7).
PMID: 37515275
PMC: 10386242.
DOI: 10.3390/v15071590.
Fluorescent and Bioluminescent Reporter Mouse-Adapted Ebola Viruses Maintain Pathogenicity and Can Be Visualized in Vivo.
Davies K, Welch S, Jain S, Sorvillo T, Coleman-McCray J, Montgomery J
J Infect Dis. 2023; 228(Suppl 7):S536-S547.
PMID: 37145895
PMC: 11014640.
DOI: 10.1093/infdis/jiad136.
Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates.
Gunn B, McNamara R, Wood L, Taylor S, Devadhasan A, Guo W
Cell Rep. 2023; 42(4):112402.
PMID: 37061918
PMC: 10576837.
DOI: 10.1016/j.celrep.2023.112402.
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes.
Chen E, Gilchuk P, Zost S, Ilinykh P, Binshtein E, Huang K
Cell Rep. 2023; 42(4):112370.
PMID: 37029928
PMC: 10556194.
DOI: 10.1016/j.celrep.2023.112370.
Animal Model Alternatives in Filovirus and Bornavirus Research.
Widerspick L, Steffen J, Tappe D, Munoz-Fontela C
Viruses. 2023; 15(1).
PMID: 36680198
PMC: 9863967.
DOI: 10.3390/v15010158.
Of mice and Mike-An underappreciated Ebola virus disease model may have paved the road for future filovirology.
Kuhn J, Schmaljohn C
Antiviral Res. 2023; 210:105522.
PMID: 36592667
PMC: 9852096.
DOI: 10.1016/j.antiviral.2022.105522.
Mouse models of Ebola virus tolerance and lethality: characterization of CD-1 mice infected with wild-type, guinea pig-adapted, or mouse-adapted virus.
Spengler J, Welch S, Ritter J, Harmon J, Coleman-McCray J, Genzer S
Antiviral Res. 2022; 210:105496.
PMID: 36567020
PMC: 11871643.
DOI: 10.1016/j.antiviral.2022.105496.